New York State Common Retirement Fund Marker Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.68 - $2.88 $411 - $705	-245 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$1.88 - $3.56 $25,859 - $48,967	-13,755 Reduced 98.25%	245 $1,000
Q4 2019 Feb 05, 2020	SELL	$2.68 - $4.85 $36,448 - $65,960	-13,600 Reduced 49.28%	14,000 $40,000
Q2 2019 Aug 09, 2019	BUY	$5.15 - $7.92 $142,140 - $218,592	27,600 New	27,600 $219,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $164M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.